The Effect of Botulinum Toxin Type A on Symptoms and Serum 5-HT, DA, TNF-α Levels in Facial Dystonia
This study demonstrates that intramuscular Botulinum Toxin Type A (BTX-A) significantly alleviates facial dystonia symptoms and normalizes blink reflex parameters by modulating serum levels of 5-HT, DA, and TNF-α, suggesting a therapeutic mechanism that extends beyond peripheral neuromuscular blockade to involve complex central neural pathways affecting emotional and sleep-related functions.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.